Your browser is no longer supported. Please, upgrade your browser.
Settings
FOLD [NASD]
Amicus Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.97 Insider Own1.00% Shs Outstand264.37M Perf Week-2.67%
Market Cap2.49B Forward P/E- EPS next Y-0.43 Insider Trans-13.86% Shs Float239.65M Perf Month-8.13%
Income-253.60M PEG- EPS next Q-0.21 Inst Own- Short Float12.42% Perf Quarter-24.50%
Sales266.80M P/S9.34 EPS this Y27.90% Inst Trans0.67% Short Ratio8.79 Perf Half Y-56.57%
Book/sh0.95 P/B9.99 EPS next Y52.30% ROA-30.70% Target Price- Perf Year-14.81%
Cash/sh1.59 P/C5.97 EPS next 5Y-1.00% ROE-83.20% 52W Range8.83 - 25.39 Perf YTD-58.90%
Dividend- P/FCF- EPS past 5Y2.30% ROI-38.00% 52W High-63.06% Beta1.15
Dividend %- Quick Ratio4.90 Sales past 5Y- Gross Margin88.40% 52W Low6.23% ATR0.41
Employees483 Current Ratio5.00 Sales Q/Q9.80% Oper. Margin-85.90% RSI (14)42.30 Volatility4.71% 3.84%
OptionableYes Debt/Eq1.55 EPS Q/Q28.20% Profit Margin-95.10% Rel Volume0.18 Prev Close9.49
ShortableYes LT Debt/Eq1.55 EarningsMay 10 BMO Payout- Avg Volume3.38M Price9.38
Recom2.60 SMA20-4.18% SMA50-5.21% SMA200-41.07% Volume34,170 Change-1.16%
Apr-14-21Upgrade Cantor Fitzgerald Neutral → Overweight $17
Mar-02-21Initiated Stifel Hold $13
Feb-12-21Downgrade JP Morgan Overweight → Neutral $19
Feb-12-21Downgrade Cantor Fitzgerald Overweight → Neutral $30 → $17
Dec-28-20Resumed Cantor Fitzgerald Overweight $20 → $30
Dec-10-20Downgrade Citigroup Buy → Neutral $20 → $27
Nov-11-20Initiated Berenberg Hold
Jun-17-20Initiated BTIG Research Buy $19
Feb-04-20Resumed Cantor Fitzgerald Overweight $19 → $20
Nov-12-19Reiterated H.C. Wainwright Buy $18 → $20
Jun-17-19Initiated H.C. Wainwright Buy $18
Jun-05-19Reiterated Cantor Fitzgerald Overweight $20 → $19
Apr-05-19Initiated Janney Buy
Jan-30-19Initiated Cantor Fitzgerald Overweight $20
Oct-29-18Initiated Citigroup Neutral $12
Aug-17-18Downgrade Chardan Capital Markets Buy → Neutral $18 → $15
Oct-06-17Resumed Goldman Neutral
Sep-13-17Reiterated Chardan Capital Markets Buy $17.50 → $16.50
Aug-10-17Reiterated Chardan Capital Markets Buy $12.50 → $17.50
Jan-24-17Upgrade Robert W. Baird Neutral → Outperform $7 → $10
May-11-21 11:55AM  
May-10-21 06:30PM  
09:05AM  
07:00AM  
06:45AM  
May-07-21 07:00AM  
May-06-21 07:00AM  
May-05-21 01:21PM  
07:00AM  
May-03-21 03:01PM  
08:30AM  
07:00AM  
Apr-28-21 07:00AM  
Apr-26-21 07:00AM  
Apr-18-21 05:40AM  
Apr-14-21 12:33PM  
Apr-08-21 10:47AM  
Mar-15-21 07:00AM  
Mar-02-21 12:51PM  
01:30AM  
Mar-01-21 08:35AM  
07:24AM  
07:00AM  
06:30AM  
Feb-26-21 10:10AM  
Feb-18-21 07:00AM  
Feb-17-21 07:00AM  
Feb-12-21 04:22PM  
10:06AM  
07:55AM  
07:19AM  
Feb-11-21 04:01PM  
Feb-08-21 02:30PM  
02:30PM  
Jan-28-21 08:40AM  
Jan-21-21 07:00AM  
Jan-18-21 02:37AM  
Jan-11-21 07:00AM  
Jan-05-21 07:00AM  
Dec-21-20 11:36AM  
Dec-18-20 02:00PM  
Dec-15-20 08:42AM  
Dec-13-20 03:16AM  
Dec-07-20 07:00AM  
Dec-05-20 11:32AM  
Dec-02-20 03:52PM  
07:00AM  
Dec-01-20 07:00AM  
Nov-23-20 07:00AM  
Nov-19-20 09:16AM  
Nov-07-20 09:29AM  
Nov-06-20 06:30PM  
10:52AM  
Nov-05-20 09:15AM  
07:00AM  
06:30AM  
Nov-02-20 07:00AM  
Oct-29-20 12:34PM  
Oct-26-20 07:02AM  
Oct-22-20 07:00AM  
Oct-18-20 08:31AM  
Oct-12-20 08:22AM  
07:00AM  
Sep-24-20 07:00AM  
Sep-15-20 09:07AM  
Sep-09-20 11:30AM  
Sep-04-20 06:37AM  
Sep-03-20 07:00AM  
Aug-10-20 07:01PM  
08:25AM  
07:27AM  
07:00AM  
Aug-04-20 07:00AM  
Aug-03-20 12:31PM  
Jul-31-20 07:42AM  
Jul-28-20 07:00AM  
Jul-17-20 08:04AM  
07:32AM  
Jul-12-20 08:16PM  
Jun-22-20 09:23AM  
Jun-08-20 03:38AM  
Jun-06-20 11:31AM  
Jun-04-20 07:00AM  
May-21-20 02:25PM  
May-19-20 09:47AM  
May-10-20 09:50AM  
May-09-20 01:31PM  
May-08-20 11:46AM  
07:00AM  
May-07-20 09:25AM  
07:00AM  
May-06-20 07:00AM  
May-05-20 07:00AM  
Apr-30-20 12:33PM  
Apr-24-20 07:00AM  
Apr-13-20 08:42AM  
Apr-01-20 11:30AM  
Mar-28-20 08:38PM  
Mar-24-20 10:00AM  
Mar-23-20 07:00AM  
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for people living with rare metabolic diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data; gene therapies for Fabry and Pompe diseases, as well as for various types of Batten diseases; enzyme replacement therapies for Pompe diseases; and CDKL5 deficiency disorder product candidates. The company also has additional gene therapies in active preclinical development, including gene therapies for mucopolysaccharidosis type IIIB, as well as a next generation program in mucopolysaccharidosis type IIIA. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Campbell Bradley LChief Operating OfficerMay 03Option Exercise6.4510,51467,815422,536May 05 05:59 PM
MCGLYNN MARGARET GDirectorMay 03Option Exercise7.5110,00075,10037,919May 05 06:01 PM
WHITMAN BURKE WDirectorMay 03Buy10.211,50015,31545,967May 05 06:00 PM
MCGLYNN MARGARET GDirectorMay 03Sale10.2710,000102,70427,919May 05 06:01 PM
Crowley John FChairman & CEOMay 03Sale10.287,50077,089884,730May 05 05:59 PM
Campbell Bradley LChief Operating OfficerMay 03Sale10.2710,514107,970412,022May 05 05:59 PM
Crowley John FChairman & CEOApr 22Sale10.017,68376,898892,230Apr 26 05:37 PM
Crowley John FChairman & CEOApr 15Option Exercise6.4522,000141,900921,913Apr 19 07:21 PM
Crowley John FChairman & CEOApr 15Sale10.0922,000222,086899,913Apr 19 07:21 PM
Campbell Bradley LChief Operating OfficerApr 01Option Exercise6.4510,51467,815389,371Apr 05 06:19 PM
WHITMAN BURKE WDirectorApr 01Buy10.001,50015,00044,467Apr 05 06:15 PM
Crowley John FChairman & CEOApr 01Sale10.007,50075,000821,524Apr 05 06:17 PM
Campbell Bradley LChief Operating OfficerApr 01Sale10.0310,514105,505378,857Apr 05 06:19 PM
Crowley John FChairman & CEOMar 22Sale10.297,68279,061829,024Mar 24 05:11 PM
Crowley John FChairman & CEOMar 15Option Exercise6.4522,000141,900858,706Mar 17 07:11 PM
Crowley John FChairman & CEOMar 15Sale10.7722,000236,988836,706Mar 17 07:11 PM
Quimi DaphneChief Financial OfficerMar 05Option Exercise2.9416,62848,886275,998Mar 09 05:38 PM
Campbell Bradley LChief Operating OfficerMar 01Option Exercise6.4510,51467,815389,371Mar 03 07:03 PM
WHITMAN BURKE WDirectorMar 01Buy12.401,50018,60042,967Mar 03 06:58 PM
Crowley John FChairman & CEOMar 01Sale11.857,50088,881836,706Mar 03 07:04 PM
Campbell Bradley LChief Operating OfficerMar 01Sale11.8410,514124,516378,857Mar 03 07:03 PM
Crowley John FChairman & CEOFeb 22Sale11.987,68292,027844,206Feb 24 05:07 PM
Crowley John FChairman & CEOFeb 16Option Exercise6.4522,000141,900873,888Feb 18 06:48 PM
Crowley John FChairman & CEOFeb 16Sale12.2622,000269,700851,888Feb 18 06:48 PM
Campbell Bradley LChief Operating OfficerFeb 01Option Exercise6.4510,51467,815389,371Feb 03 05:58 PM
WHITMAN BURKE WDirectorFeb 01Buy19.091,50028,63741,467Feb 03 06:00 PM
Campbell Bradley LChief Operating OfficerFeb 01Sale19.0810,514200,571378,857Feb 03 05:58 PM
Crowley John FChairman & CEOFeb 01Sale19.087,500143,077851,888Feb 03 05:59 PM
Crowley John FChairman & CEOJan 20Sale21.5150,0001,075,325859,388Jan 20 06:14 PM
Crowley John FChairman & CEOJan 15Option Exercise6.4522,000141,900931,388Jan 20 06:14 PM
Crowley John FChairman & CEOJan 15Sale22.2422,000489,368909,388Jan 20 06:14 PM
Campbell Bradley LChief Operating OfficerJan 04Option Exercise6.4510,51467,815316,847Jan 05 07:40 PM
WHITMAN BURKE WDirectorJan 04Buy23.171,50034,75539,967Jan 05 07:31 PM
Crowley John FChairman & CEOJan 04Sale22.177,500166,305745,429Jan 05 08:07 PM
Campbell Bradley LChief Operating OfficerJan 04Sale22.1710,514233,125306,333Jan 05 07:40 PM
Quimi DaphneChief Financial OfficerDec 21Option Exercise2.945,00014,700249,344Dec 23 05:45 PM
Quimi DaphneChief Financial OfficerDec 21Sale24.095,000120,474244,344Dec 23 05:45 PM
Quimi DaphneChief Financial OfficerDec 15Option Exercise3.2730,32199,222248,500Dec 17 04:32 PM
Campbell Bradley LChief Operating OfficerDec 15Option Exercise5.4520,828113,597359,592Dec 17 04:31 PM
Crowley John FChairman & CEODec 15Option Exercise6.4522,000141,900845,513Dec 16 05:16 PM
Crowley John FChairman & CEODec 15Sale23.9122,000526,101823,513Dec 16 05:16 PM
Do HungChief Science OfficerDec 14Sale23.88111,1252,653,276409,682Dec 16 05:15 PM
Campbell Bradley LChief Operating OfficerDec 01Option Exercise2.5224,78362,453363,547Dec 02 06:39 PM
WHITMAN BURKE WDirectorDec 01Buy23.501,50035,25038,467Dec 03 06:27 PM
Crowley John FChairman & CEODec 01Sale22.777,500170,776823,513Dec 02 06:41 PM
Campbell Bradley LChief Operating OfficerDec 01Sale22.7724,783564,192338,764Dec 02 06:39 PM
Prout SamanthaPrincipal Accounting OfficerNov 04Option Exercise14.405,93185,37823,066Nov 06 05:57 PM
Prout SamanthaPrincipal Accounting OfficerNov 04Sale20.005,931118,62017,135Nov 06 05:57 PM
Campbell Bradley LChief Operating OfficerNov 02Option Exercise2.5224,78262,451363,546Nov 04 07:11 PM
Crowley John FChairman & CEONov 02Option Exercise5.9623,975142,891864,888Nov 04 07:24 PM
WHITMAN BURKE WDirectorNov 02Buy18.011,50027,01536,967Nov 04 07:25 PM
Crowley John FChairman & CEONov 02Sale17.8733,875605,272831,013Nov 04 07:24 PM
Campbell Bradley LChief Operating OfficerNov 02Sale17.8724,782442,792338,764Nov 04 07:11 PM
Do HungChief Science OfficerOct 09Option Exercise10.19193,7001,974,507714,507Oct 13 05:00 PM
Do HungChief Science OfficerOct 09Sale15.03193,7002,911,272520,807Oct 13 05:00 PM
Quimi DaphneChief Financial OfficerOct 02Option Exercise2.4511,00026,950218,179Oct 05 05:10 PM
Quimi DaphneChief Financial OfficerOct 01Option Exercise2.945,00014,700212,179Oct 05 05:10 PM
Crowley John FChairman & CEOOct 01Option Exercise5.9620,000119,200870,813Oct 05 05:11 PM
WHITMAN BURKE WDirectorOct 01Buy14.281,50021,41335,467Oct 05 05:12 PM
Quimi DaphneChief Financial OfficerOct 01Sale14.025,00070,099207,179Oct 05 05:10 PM
Crowley John FChairman & CEOOct 01Sale14.0229,900419,105840,913Oct 05 05:11 PM
Barth JayChief Medical OfficerSep 30Option Exercise2.294,0649,307167,268Oct 02 04:34 PM
Barth JayChief Medical OfficerSep 30Sale14.514,06458,951163,204Oct 02 04:34 PM
Campbell Bradley LChief Operating OfficerSep 28Option Exercise2.5224,78262,451363,546Sep 30 04:38 PM
Campbell Bradley LChief Operating OfficerSep 28Sale13.8924,782344,205338,764Sep 30 04:38 PM
Crowley John FChairman & CEOSep 01Option Exercise5.9620,000119,200880,713Sep 02 04:28 PM
WHITMAN BURKE WDirectorSep 01Buy14.621,50021,93033,967Sep 02 04:28 PM
Crowley John FChairman & CEOSep 01Sale14.1829,900423,850850,813Sep 02 04:28 PM
Barth JayChief Medical OfficerAug 31Option Exercise6.1028,750175,375191,954Sep 02 04:27 PM
Barth JayChief Medical OfficerAug 31Sale14.7428,750423,746163,204Sep 02 04:27 PM
Crowley John FChairman & CEOAug 17Option Exercise5.1320,000102,600880,713Aug 19 04:56 PM
Crowley John FChairman & CEOAug 17Sale14.8920,000297,814860,713Aug 19 04:56 PM
Prout SamanthaPrincipal Accounting OfficerAug 05Option Exercise10.041981,98817,333Aug 07 08:04 PM
Prout SamanthaPrincipal Accounting OfficerAug 05Sale15.051982,98017,135Aug 07 08:04 PM
Crowley John FChairman & CEOAug 03Option Exercise5.9620,000119,200900,368Aug 05 04:02 PM
Campbell Bradley LChief Operating OfficerAug 03Option Exercise6.0610,00060,600348,764Aug 05 04:03 PM
WHITMAN BURKE WDirectorAug 03Buy14.531,50021,79532,467Aug 05 04:05 PM
Campbell Bradley LChief Operating OfficerAug 03Sale14.7810,000147,779338,764Aug 05 04:03 PM
Crowley John FChairman & CEOAug 03Sale14.7839,655586,081860,713Aug 05 04:02 PM
Barth JayChief Medical OfficerJul 27Option Exercise6.1030,000183,000193,204Jul 29 09:41 PM
Barth JayChief Medical OfficerJul 27Sale15.0530,000451,377163,204Jul 29 09:41 PM
Rosenberg EllenChief Legal OfficerJul 16Option Exercise5.1630,000154,800225,169Jul 20 05:31 PM
Rosenberg EllenChief Legal OfficerJul 16Sale15.2630,000457,911195,169Jul 20 05:31 PM
Crowley John FChairman & CEOJul 15Option Exercise5.1320,000102,600900,368Jul 17 06:28 PM
Crowley John FChairman & CEOJul 15Sale15.5420,000310,848880,368Jul 17 06:28 PM
Barth JayChief Medical OfficerJul 10Option Exercise5.1328,843147,965192,047Jul 13 06:54 PM
Barth JayChief Medical OfficerJul 10Sale15.6528,843451,433163,204Jul 13 06:54 PM
Barth JayChief Medical OfficerJul 09Option Exercise10.3744,447460,867207,651Jul 13 06:54 PM
Barth JayChief Medical OfficerJul 09Sale15.9244,447707,494163,204Jul 13 06:54 PM
Campbell Bradley LChief Operating OfficerJul 08Option Exercise6.062,50015,150341,264Jul 09 06:47 PM
Barth JayChief Medical OfficerJul 08Option Exercise10.1764,110652,165227,314Jul 09 06:51 PM
Campbell Bradley LChief Operating OfficerJul 08Sale16.012,50040,025338,764Jul 09 06:47 PM
Barth JayChief Medical OfficerJul 08Sale15.9264,1101,020,574163,204Jul 09 06:51 PM
Barth JayChief Medical OfficerJul 07Option Exercise9.89178,9881,770,220342,192Jul 09 06:51 PM
Barth JayChief Medical OfficerJul 07Sale15.90178,9882,845,945163,204Jul 09 06:51 PM
Prout SamanthaPrincipal Accounting OfficerJul 02Option Exercise10.041981,9881,733Jul 06 07:50 PM
Prout SamanthaPrincipal Accounting OfficerJul 02Sale15.801983,12817,135Jul 06 07:50 PM
Crowley John FChairman & CEOJul 01Option Exercise5.9620,000119,200920,023Jul 06 07:45 PM
Campbell Bradley LChief Operating OfficerJul 01Option Exercise6.0612,50075,750351,264Jul 06 07:47 PM
Quimi DaphneChief Financial OfficerJul 01Option Exercise2.6219,87252,054214,051Jul 06 07:38 PM